Standard Biotools logo

Standard Biotools Share Price Today

(NASDAQ: LAB)

Standard Biotools share price is $1.16 & ₹99.14 as on 18 Apr 2025, 2.30 'hrs' IST

$1.16

0.03

(2.65%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Standard Biotools share price in Dollar and Rupees. Guide to invest in Standard Biotools stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Standard Biotools, along with analyst recommendations, forecasts, and comprehensive financials.

Standard Biotools share price movements

  • Today's Low: $1.10
    Today's High: $1.17

    Day's Volatility :5.58%

  • 52 Weeks Low: $0.97
    52 Weeks High: $2.74

    52 Weeks Volatility :64.55%

Standard Biotools (LAB) Returns

PeriodStandard Biotools IncSector (Health Care)Index (Russel 2000)
3 Months
-38.3%
-2.8%
0.0%
6 Months
-38.3%
-11.0%
0.0%
1 Year
-53.97%
-1.9%
0.0%
3 Years
-60.0%
-1.5%
-12.9%

Standard Biotools (LAB) Key Statistics

in dollars & INR

Previous Close
$1.13
Open
$1.13
Today's High
$1.165
Today's Low
$1.1
Market Capitalization
$439.6M
Today's Volume
$693.3K
52 Week High
$2.74
52 Week Low
$0.9712
Revenue TTM
$174.4M
EBITDA
$-117.9M
Earnings Per Share (EPS)
$-0.53
Profit Margin
-79.62%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-43.75%

How to invest in Standard Biotools Stock (LAB) from India?

It is very easy for Indian residents to invest directly in Standard Biotools from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Standard Biotools stock in both Indian Rupees (INR) and US Dollars (USD). Search for Standard Biotools or LAB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Standard Biotools or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Standard Biotools shares which would translate to 0.737 fractional shares of Standard Biotools as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Standard Biotools, in just a few clicks!

Returns in Standard Biotools (LAB) for Indian investors in Rupees

The Standard Biotools stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Standard Biotools investment value today

Current value as on today

₹48,373

Returns

₹51,627

(-51.63%)

Returns from Standard Biotools Stock

₹53,968 (-53.97%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Standard Biotools (LAB)

-56%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Standard Biotools Stock from India on INDmoney has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Standard Biotools

Rating
Trend

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 6 Wall street analysts offering stock ratings for Standard Biotools(by analysts ranked 0 to 5 stars)

Analyst Forecast on Standard Biotools Stock (LAB)

What analysts predicted

Upside of 104.74%

Target:

$2.38

Current:

$1.16

Insights on Standard Biotools Stock (Ticker Symbol: LAB)

  • Price Movement

    In the last 1 year, LAB stock has moved down by -55.2%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 37.20M → 46.71M (in $), with an average increase of 10.5% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -26.93M → -34.07M (in $), with an average decrease of 26.5% per quarter
  • LAB vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 41.5% return, outperforming this stock by 96.7%
  • LAB vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 108.3% return, outperforming this stock by 173.4%
  • Price to Sales

    ForLAB every $1 of sales, investors are willing to pay $2.3, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

LAB Standard Biotools Financials in INR & Dollars

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$174.4M
↑ 64.03%
Net Income
$-138.9M
↑ 86.03%
Net Profit Margin
-79.62%
↓ 9.41%

Standard Biotools Technicals Summary

Sell

Neutral

Buy

Standard Biotools is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Standard Biotools (LAB) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Standard Biotools Inc logo
-2.59%
-38.3%
-53.97%
-60.0%
-43.69%
Medtronic Plc logo
-9.34%
-9.26%
3.93%
-26.9%
-18.65%
Edwards Lifesciences Corp. logo
0.35%
2.11%
-16.77%
-44.23%
-4.46%
Boston Scientific Corp. logo
-6.17%
8.03%
41.27%
101.95%
155.36%
Stryker Corporation logo
-7.36%
-5.65%
6.47%
25.38%
87.58%
Abbott Laboratories logo
3.31%
11.96%
22.09%
6.8%
33.65%

About Standard Biotools

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates in two segments, Proteomics and Genomics. Its proteomics and genomics include instruments, consumables, software, and services based upon technologies used in the identification of proteins, as well as genes and their functions. The company provides SomaScan platform that enables researchers to measure proteins simultaneously and provides deep insights into biological processes and disease mechanisms; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; Hyperion, a spatial biology platform, which unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark X9 system that redefines high-throughput genomics for quantitative polymerase chain reaction applications. The company sells its instruments and consumables for research use only to academic research institutions, translational research and medicine centers, cancer centers, and clinical research laboratories, as well as biopharmaceutical, biotechnology, and plant and animal research companies. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Standard BioTools Inc. was incorporated in 1999 and is headquartered in South San Francisco, California.
Organization
Standard Biotools
Employees
814
CEO
Dr. Michael Egholm Ph.D.
Industry
Technology

Management People of Standard Biotools

NameTitle
Dr. Michael Egholm Ph.D.
President, CEO & Director
Mr. Hanjoon Kim
Chief Financial Officer
Mr. Jonathan Mickelsen
VP & Chief Accounting Officer
Ms. Elizabeth R. Jensen
Chief Human Resources Officer
Mr. Sean Mackay
Chief Business Officer & Senior VP
Dr. Stephen A. Williams BS, MB, Ph.D.
Chief Medical Officer

Important FAQs about investing in LAB Stock from India :

What is Standard Biotools share price today?

Standard Biotools share price today stands at $1.16, Open: $1.13 ; Previous Close: $1.13 ; High: $1.17 ; Low: $1.10 ; 52 Week High: $2.74 ; 52 Week Low: $0.97.

The stock opens at $1.13, after a previous close of $1.13. The stock reached a daily high of $1.17 and a low of $1.10, with a 52-week high of $2.74 and a 52-week low of $0.97.

Can Indians buy Standard Biotools shares?

Yes, Indians can invest in the Standard Biotools (LAB) from India.

With INDmoney, you can buy Standard Biotools at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Standard Biotools at zero transaction cost.

How can I buy Standard Biotools shares from India?

It is very easy to buy Standard Biotools from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Standard Biotools (LAB) be purchased?

Yes, you can buy fractional shares of Standard Biotools with INDmoney app.

What are the documents required to start investing in Standard Biotools stocks?

To start investing in Standard Biotools, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Standard Biotools Stock (LAB)?

Today’s highest price of Standard Biotools (LAB) is $1.17.

Today’s lowest price of Standard Biotools (LAB) is $1.10.

What is today's market capitalisation of Standard Biotools?

Today's market capitalisation of Standard Biotools LAB is 439.6M

What is the 52 Week High and Low Range of Standard Biotools Stock (LAB)?

  • 52 Week High

    $2.74

  • 52 Week Low

    $0.97

What are the historical returns of Standard Biotools (LAB)?

  • 1 Month Returns

    -2.59%

  • 3 Months Returns

    -38.3%

  • 1 Year Returns

    -53.97%

  • 5 Years Returns

    -43.69%

Who is the Chief Executive Officer (CEO) of Standard Biotools ?

Dr. Michael Egholm Ph.D. is the current Chief Executive Officer (CEO) of Standard Biotools.

Discover More